Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE:300760)
China flag China · Delayed Price · Currency is CNY
162.73
-2.97 (-1.79%)
Sep 11, 2026, 3:04 PM CST

SHE:300760 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
34,28633,28236,72634,93230,36625,270
Revenue Growth
4.09%-9.38%5.13%15.04%20.17%20.18%
Gross Profit
20,25119,75522,95922,16419,41016,303
Operating Income
9,7019,29912,37312,26110,4098,764
Net Income
7,8648,13611,66811,5829,6078,002
Earnings Per Share
6.496.719.639.567.946.59
EPS Growth
-14.34%-30.30%0.79%20.42%20.50%20.28%

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
China
15,49715,63220,29221,38218,66715,259
Asian-Pacific
3,9193,6183,6592,6382,2812,174
Europe
3,7663,3742,8872,1911,9982,268
Latin America
3,2542,9822,8042,4222,0971,568
North America
2,7042,7022,6362,6032,4611,872
Others
5,1474,9744,4463,6962,8622,129
Total
34,28633,28236,72634,93230,36625,270

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
18,77517,94116,64418,78723,18615,361
Total Debt
311.08349.28298.49294.93236.52237.24
Net Cash (Debt)
18,46417,59216,34618,49222,94915,124
Net Cash Growth
10.19%7.62%-11.61%-19.42%51.74%-4.67%
Net Cash Per Share
15.2414.5213.4915.2618.9612.45

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
11,10010,14512,43211,06212,1418,999
Capital Expenditures
-2,085-2,038-1,959-2,689-1,916-1,402
Free Cash Flow
9,0158,10710,4738,37310,2267,596
Free Cash Flow Growth
55.62%-22.59%25.07%-18.11%34.62%-1.19%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
59.06%59.36%62.51%63.45%63.92%64.52%
Operating Margin
28.29%27.94%33.69%35.10%34.28%34.68%
Pretax Margin
27.16%29.07%35.45%37.25%36.07%35.68%
Profit Margin
22.94%24.45%31.77%33.16%31.64%31.66%
FCF Margin
26.29%24.36%28.52%23.97%33.67%30.06%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
4.3804.3806.2705.8004.5003.500
Dividend Per Share Growth
-37.58%-30.14%8.10%28.89%28.57%40.00%
Dividend Yield
2.58%2.34%2.56%2.13%1.57%1.02%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
25.0828.3126.4330.3439.7857.71
Forward PE
21.5224.2822.3226.6834.8648.63
P/FCF Ratio
21.8328.4129.4541.9737.3760.79
PS Ratio
5.746.928.4010.0612.5818.27